Hayoz D, Ziegler T, Brunner H R, Ruiz J
Division of Hypertension and Vascular Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Metabolism. 1998 Dec;47(12 Suppl 1):16-9. doi: 10.1016/s0026-0495(98)90365-1.
Cardiovascular complications represent by far the most severe manifestations of diabetes mellitus. Treatment aimed at stopping progression of vascular lesions may fall short if initiated when the disease becomes clinically evident. Therefore, identification of the earliest vascular disfunctions may offer the best opportunity to interfere with pathogenic mechanisms and avoid progression of diabetic vasculopathy. In this report, we present a few mechanisms that alter hemodynamic and metabolic homeostasis in the course of diabetes mellitus. Endothelial function with special emphasis on nitric oxide and oxidative stress, advanced glycation end products, and the renin angiotensin system are briefly discussed. New pharmacological agents that may favorably influence these parameters are presently undergoing clinical trials. However, tight control of plasma glucose and cardiovascular risk factors represent the cornerstone of the treatment in diabetes to slow progression of vascular disease.
心血管并发症是迄今为止糖尿病最严重的表现形式。如果在疾病出现临床症状时才开始治疗,旨在阻止血管病变进展的治疗可能效果不佳。因此,识别最早的血管功能障碍可能为干预致病机制和避免糖尿病血管病变进展提供最佳机会。在本报告中,我们介绍了一些在糖尿病过程中改变血流动力学和代谢稳态的机制。简要讨论了内皮功能,特别强调一氧化氮和氧化应激、晚期糖基化终产物以及肾素血管紧张素系统。可能对这些参数产生有利影响的新型药物目前正在进行临床试验。然而,严格控制血糖和心血管危险因素是糖尿病治疗中减缓血管疾病进展的基石。